A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study

Bibliographische Detailangaben

Veröffentlicht in:	Haematologica (Roma) 2022-10, Vol.107 (10), p.2496-2500
Hauptverfasser:	Popat, Uday R, Andersson, Borje S, Bassett, Roland, Kawedia, Jitesh, Valdez, Ben C, Alousi, Amin M, Al-Atrash, Gheath, Bashir, Qaiser, Hosing, Chitra M, Im, Jin S, Kebriaei, Partow, Marin, David, Nieto, Yago, Oran, Betul, Olson, Amanda, Qazilbash, Muzaffar H, Srour, Samer A, Shpall, Elizabeth J, Champlin, Richard E, Mehta, Rohtesh S
Format:	Artikel
Sprache:	eng
Schlagworte:	Busulfan Cyclophosphamide - therapeutic use Graft vs Host Disease - etiology Graft vs Host Disease - prevention & control Hematopoietic Stem Cell Transplantation - methods Humans Letter to the Editor Myeloablative Agonists Transplantation Conditioning - methods Transplantation, Haploidentical
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!